nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ALB—coronary artery disease	0.107	1	CbGaD
Mirabegron—ADRB3—Timolol—coronary artery disease	0.0628	0.095	CbGbCtD
Mirabegron—ORM1—Penbutolol—coronary artery disease	0.0441	0.0667	CbGbCtD
Mirabegron—ORM1—Pitavastatin—coronary artery disease	0.0385	0.0583	CbGbCtD
Mirabegron—BCHE—Perindopril—coronary artery disease	0.0382	0.0578	CbGbCtD
Mirabegron—BCHE—Ramipril—coronary artery disease	0.0317	0.0479	CbGbCtD
Mirabegron—SLCO1A2—Enalapril—coronary artery disease	0.0297	0.045	CbGbCtD
Mirabegron—SLCO1A2—Rosuvastatin—coronary artery disease	0.0231	0.035	CbGbCtD
Mirabegron—SLCO1A2—Simvastatin—coronary artery disease	0.0215	0.0325	CbGbCtD
Mirabegron—SLCO1A2—Pravastatin—coronary artery disease	0.021	0.0318	CbGbCtD
Mirabegron—SLCO1A2—Lovastatin—coronary artery disease	0.021	0.0318	CbGbCtD
Mirabegron—SLCO1A2—Atorvastatin—coronary artery disease	0.0192	0.029	CbGbCtD
Mirabegron—ALB—Pitavastatin—coronary artery disease	0.0162	0.0245	CbGbCtD
Mirabegron—ALB—Valsartan—coronary artery disease	0.0158	0.0239	CbGbCtD
Mirabegron—ABCB1—Ticagrelor—coronary artery disease	0.0157	0.0238	CbGbCtD
Mirabegron—ALB—Rosuvastatin—coronary artery disease	0.012	0.0181	CbGbCtD
Mirabegron—ALB—Acetylsalicylic acid—coronary artery disease	0.0116	0.0176	CbGbCtD
Mirabegron—ALB—Captopril—coronary artery disease	0.0115	0.0174	CbGbCtD
Mirabegron—ABCB1—Perindopril—coronary artery disease	0.0097	0.0147	CbGbCtD
Mirabegron—ABCB1—Clopidogrel—coronary artery disease	0.0097	0.0147	CbGbCtD
Mirabegron—CYP3A4—Ticagrelor—coronary artery disease	0.00941	0.0142	CbGbCtD
Mirabegron—ALB—Furosemide—coronary artery disease	0.00925	0.014	CbGbCtD
Mirabegron—ALB—Losartan—coronary artery disease	0.00906	0.0137	CbGbCtD
Mirabegron—ABCB1—Telmisartan—coronary artery disease	0.00848	0.0128	CbGbCtD
Mirabegron—ABCB1—Pitavastatin—coronary artery disease	0.00848	0.0128	CbGbCtD
Mirabegron—CYP3A4—Fenofibrate—coronary artery disease	0.00839	0.0127	CbGbCtD
Mirabegron—ABCB1—Enalapril—coronary artery disease	0.00804	0.0122	CbGbCtD
Mirabegron—ABCB1—Lisinopril—coronary artery disease	0.00804	0.0122	CbGbCtD
Mirabegron—CYP2D6—Niacin—coronary artery disease	0.00693	0.0105	CbGbCtD
Mirabegron—ABCB1—Timolol—coronary artery disease	0.00684	0.0103	CbGbCtD
Mirabegron—CYP3A4—Gemfibrozil—coronary artery disease	0.0067	0.0101	CbGbCtD
Mirabegron—CYP2D6—Timolol—coronary artery disease	0.00644	0.00974	CbGbCtD
Mirabegron—ABCB1—Ezetimibe—coronary artery disease	0.00625	0.00946	CbGbCtD
Mirabegron—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00609	0.00922	CbGbCtD
Mirabegron—ABCB1—Captopril—coronary artery disease	0.00602	0.0091	CbGbCtD
Mirabegron—CYP3A4—Clopidogrel—coronary artery disease	0.00581	0.00879	CbGbCtD
Mirabegron—ABCB1—Simvastatin—coronary artery disease	0.00581	0.00879	CbGbCtD
Mirabegron—ABCB1—Pravastatin—coronary artery disease	0.00569	0.0086	CbGbCtD
Mirabegron—ABCB1—Lovastatin—coronary artery disease	0.00569	0.0086	CbGbCtD
Mirabegron—CYP2D6—Captopril—coronary artery disease	0.00567	0.00858	CbGbCtD
Mirabegron—CYP2D6—Simvastatin—coronary artery disease	0.00548	0.00828	CbGbCtD
Mirabegron—CYP3A4—Eplerenone—coronary artery disease	0.0054	0.00817	CbGbCtD
Mirabegron—CYP2D6—Pravastatin—coronary artery disease	0.00536	0.00811	CbGbCtD
Mirabegron—CYP2D6—Lovastatin—coronary artery disease	0.00536	0.00811	CbGbCtD
Mirabegron—ABCB1—Atorvastatin—coronary artery disease	0.00518	0.00784	CbGbCtD
Mirabegron—CYP2D6—Atorvastatin—coronary artery disease	0.00488	0.00738	CbGbCtD
Mirabegron—CYP3A4—Enalapril—coronary artery disease	0.00482	0.00729	CbGbCtD
Mirabegron—ABCB1—Losartan—coronary artery disease	0.00474	0.00717	CbGbCtD
Mirabegron—CYP3A4—Rosuvastatin—coronary artery disease	0.00375	0.00567	CbGbCtD
Mirabegron—CYP3A4—Ezetimibe—coronary artery disease	0.00375	0.00567	CbGbCtD
Mirabegron—CYP3A4—Simvastatin—coronary artery disease	0.00348	0.00527	CbGbCtD
Mirabegron—CYP3A4—Pravastatin—coronary artery disease	0.00341	0.00515	CbGbCtD
Mirabegron—CYP3A4—Lovastatin—coronary artery disease	0.00341	0.00515	CbGbCtD
Mirabegron—CYP3A4—Atorvastatin—coronary artery disease	0.0031	0.00469	CbGbCtD
Mirabegron—CYP3A4—Losartan—coronary artery disease	0.00284	0.00429	CbGbCtD
Mirabegron—Arbutamine—ADRB1—coronary artery disease	0.000677	0.271	CrCbGaD
Mirabegron—Arbutamine—ADRB2—coronary artery disease	0.00057	0.228	CrCbGaD
Mirabegron—Labetalol—ADRB1—coronary artery disease	0.00048	0.192	CrCbGaD
Mirabegron—Labetalol—ADRB2—coronary artery disease	0.000404	0.162	CrCbGaD
Mirabegron—Propafenone—ADRB1—coronary artery disease	0.000367	0.147	CrCbGaD
Mirabegron—Urticaria—Valsartan—coronary artery disease	0.000122	0.000785	CcSEcCtD
Mirabegron—Nausea—Rosuvastatin—coronary artery disease	0.000122	0.000784	CcSEcCtD
Mirabegron—Diarrhoea—Fenofibrate—coronary artery disease	0.000122	0.000784	CcSEcCtD
Mirabegron—Constipation—Enalapril—coronary artery disease	0.000122	0.000782	CcSEcCtD
Mirabegron—Urticaria—Olmesartan—coronary artery disease	0.000122	0.000781	CcSEcCtD
Mirabegron—Abdominal pain—Valsartan—coronary artery disease	0.000122	0.000781	CcSEcCtD
Mirabegron—Tachycardia—Losartan—coronary artery disease	0.000122	0.00078	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000121	0.000779	CcSEcCtD
Mirabegron—Fatigue—Telmisartan—coronary artery disease	0.000121	0.000778	CcSEcCtD
Mirabegron—Abdominal pain—Olmesartan—coronary artery disease	0.000121	0.000777	CcSEcCtD
Mirabegron—Pruritus—Ezetimibe—coronary artery disease	0.000121	0.000776	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000121	0.000776	CcSEcCtD
Mirabegron—Vision blurred—Timolol—coronary artery disease	0.000121	0.000773	CcSEcCtD
Mirabegron—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000121	0.000773	CcSEcCtD
Mirabegron—Dyspepsia—Captopril—coronary artery disease	0.00012	0.000772	CcSEcCtD
Mirabegron—Constipation—Telmisartan—coronary artery disease	0.00012	0.000772	CcSEcCtD
Mirabegron—Diarrhoea—Clopidogrel—coronary artery disease	0.00012	0.00077	CcSEcCtD
Mirabegron—Asthenia—Eplerenone—coronary artery disease	0.00012	0.00077	CcSEcCtD
Mirabegron—Diarrhoea—Lovastatin—coronary artery disease	0.000119	0.000765	CcSEcCtD
Mirabegron—Urticaria—Niacin—coronary artery disease	0.000119	0.000763	CcSEcCtD
Mirabegron—Nausea—Acetylsalicylic acid—coronary artery disease	0.000119	0.000762	CcSEcCtD
Mirabegron—Pruritus—Eplerenone—coronary artery disease	0.000118	0.00076	CcSEcCtD
Mirabegron—Abdominal pain—Niacin—coronary artery disease	0.000118	0.000759	CcSEcCtD
Mirabegron—Dizziness—Fenofibrate—coronary artery disease	0.000118	0.000757	CcSEcCtD
Mirabegron—Fatigue—Captopril—coronary artery disease	0.000118	0.000756	CcSEcCtD
Mirabegron—Urticaria—Pravastatin—coronary artery disease	0.000117	0.000751	CcSEcCtD
Mirabegron—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000117	0.000751	CcSEcCtD
Mirabegron—Asthenia—Simvastatin—coronary artery disease	0.000117	0.000751	CcSEcCtD
Mirabegron—Diarrhoea—Ezetimibe—coronary artery disease	0.000117	0.000751	CcSEcCtD
Mirabegron—Constipation—Captopril—coronary artery disease	0.000117	0.00075	CcSEcCtD
Mirabegron—Dyspepsia—Perindopril—coronary artery disease	0.000117	0.00075	CcSEcCtD
Mirabegron—Gastrointestinal pain—Enalapril—coronary artery disease	0.000117	0.000748	CcSEcCtD
Mirabegron—Abdominal pain—Pravastatin—coronary artery disease	0.000117	0.000748	CcSEcCtD
Mirabegron—Dizziness—Clopidogrel—coronary artery disease	0.000116	0.000744	CcSEcCtD
Mirabegron—Palpitations—Ramipril—coronary artery disease	0.000116	0.000742	CcSEcCtD
Mirabegron—Pruritus—Simvastatin—coronary artery disease	0.000115	0.00074	CcSEcCtD
Mirabegron—Dizziness—Lovastatin—coronary artery disease	0.000115	0.00074	CcSEcCtD
Mirabegron—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000115	0.000738	CcSEcCtD
Mirabegron—Back pain—Lisinopril—coronary artery disease	0.000115	0.000736	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000115	0.000735	CcSEcCtD
Mirabegron—Diarrhoea—Eplerenone—coronary artery disease	0.000114	0.000735	CcSEcCtD
Mirabegron—Fatigue—Perindopril—coronary artery disease	0.000114	0.000734	CcSEcCtD
Mirabegron—Urticaria—Trandolapril—coronary artery disease	0.000114	0.00073	CcSEcCtD
Mirabegron—Constipation—Perindopril—coronary artery disease	0.000114	0.000728	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000113	0.000728	CcSEcCtD
Mirabegron—Urticaria—Enalapril—coronary artery disease	0.000113	0.000727	CcSEcCtD
Mirabegron—Abdominal pain—Trandolapril—coronary artery disease	0.000113	0.000726	CcSEcCtD
Mirabegron—Dizziness—Ezetimibe—coronary artery disease	0.000113	0.000725	CcSEcCtD
Mirabegron—Palpitations—Timolol—coronary artery disease	0.000113	0.000725	CcSEcCtD
Mirabegron—Abdominal pain—Enalapril—coronary artery disease	0.000113	0.000723	CcSEcCtD
Mirabegron—Rash—Fenofibrate—coronary artery disease	0.000113	0.000722	CcSEcCtD
Mirabegron—Dermatitis—Fenofibrate—coronary artery disease	0.000112	0.000721	CcSEcCtD
Mirabegron—Headache—Fenofibrate—coronary artery disease	0.000112	0.000718	CcSEcCtD
Mirabegron—Vision blurred—Lisinopril—coronary artery disease	0.000112	0.000717	CcSEcCtD
Mirabegron—Gastrointestinal pain—Captopril—coronary artery disease	0.000112	0.000717	CcSEcCtD
Mirabegron—Urticaria—Telmisartan—coronary artery disease	0.000112	0.000717	CcSEcCtD
Mirabegron—Diarrhoea—Simvastatin—coronary artery disease	0.000112	0.000716	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000111	0.000715	CcSEcCtD
Mirabegron—Arthralgia—Ramipril—coronary artery disease	0.000111	0.000715	CcSEcCtD
Mirabegron—Fatigue—Furosemide—coronary artery disease	0.000111	0.000714	CcSEcCtD
Mirabegron—Abdominal pain—Telmisartan—coronary artery disease	0.000111	0.000713	CcSEcCtD
Mirabegron—Dizziness—Eplerenone—coronary artery disease	0.000111	0.00071	CcSEcCtD
Mirabegron—Rash—Clopidogrel—coronary artery disease	0.000111	0.00071	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000111	0.00071	CcSEcCtD
Mirabegron—Dermatitis—Clopidogrel—coronary artery disease	0.000111	0.000709	CcSEcCtD
Mirabegron—Asthenia—Valsartan—coronary artery disease	0.00011	0.000709	CcSEcCtD
Mirabegron—Hypertension—Timolol—coronary artery disease	0.00011	0.000708	CcSEcCtD
Mirabegron—Constipation—Furosemide—coronary artery disease	0.00011	0.000708	CcSEcCtD
Mirabegron—Asthenia—Olmesartan—coronary artery disease	0.00011	0.000705	CcSEcCtD
Mirabegron—Headache—Clopidogrel—coronary artery disease	0.00011	0.000705	CcSEcCtD
Mirabegron—Rash—Lovastatin—coronary artery disease	0.00011	0.000705	CcSEcCtD
Mirabegron—Dermatitis—Lovastatin—coronary artery disease	0.00011	0.000704	CcSEcCtD
Mirabegron—Dyspepsia—Losartan—coronary artery disease	0.00011	0.000703	CcSEcCtD
Mirabegron—Headache—Lovastatin—coronary artery disease	0.000109	0.000701	CcSEcCtD
Mirabegron—Pruritus—Valsartan—coronary artery disease	0.000109	0.000699	CcSEcCtD
Mirabegron—Dry mouth—Ramipril—coronary artery disease	0.000109	0.000699	CcSEcCtD
Mirabegron—Arthralgia—Timolol—coronary artery disease	0.000109	0.000699	CcSEcCtD
Mirabegron—Gastrointestinal pain—Perindopril—coronary artery disease	0.000109	0.000697	CcSEcCtD
Mirabegron—Pruritus—Olmesartan—coronary artery disease	0.000108	0.000696	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000108	0.000694	CcSEcCtD
Mirabegron—Abdominal pain—Captopril—coronary artery disease	0.000108	0.000694	CcSEcCtD
Mirabegron—Dizziness—Simvastatin—coronary artery disease	0.000108	0.000692	CcSEcCtD
Mirabegron—Rash—Ezetimibe—coronary artery disease	0.000108	0.000692	CcSEcCtD
Mirabegron—Dermatitis—Ezetimibe—coronary artery disease	0.000108	0.000691	CcSEcCtD
Mirabegron—Asthenia—Niacin—coronary artery disease	0.000107	0.000689	CcSEcCtD
Mirabegron—Fatigue—Losartan—coronary artery disease	0.000107	0.000689	CcSEcCtD
Mirabegron—Headache—Ezetimibe—coronary artery disease	0.000107	0.000687	CcSEcCtD
Mirabegron—Dry mouth—Timolol—coronary artery disease	0.000106	0.000683	CcSEcCtD
Mirabegron—Constipation—Losartan—coronary artery disease	0.000106	0.000683	CcSEcCtD
Mirabegron—Nausea—Fenofibrate—coronary artery disease	0.000106	0.00068	CcSEcCtD
Mirabegron—Pruritus—Niacin—coronary artery disease	0.000106	0.00068	CcSEcCtD
Mirabegron—Asthenia—Pravastatin—coronary artery disease	0.000106	0.000679	CcSEcCtD
Mirabegron—Gastrointestinal pain—Furosemide—coronary artery disease	0.000106	0.000677	CcSEcCtD
Mirabegron—Rash—Eplerenone—coronary artery disease	0.000106	0.000677	CcSEcCtD
Mirabegron—Urticaria—Perindopril—coronary artery disease	0.000105	0.000677	CcSEcCtD
Mirabegron—Dermatitis—Eplerenone—coronary artery disease	0.000105	0.000676	CcSEcCtD
Mirabegron—Diarrhoea—Valsartan—coronary artery disease	0.000105	0.000676	CcSEcCtD
Mirabegron—Abdominal pain—Perindopril—coronary artery disease	0.000105	0.000673	CcSEcCtD
Mirabegron—Palpitations—Lisinopril—coronary artery disease	0.000105	0.000673	CcSEcCtD
Mirabegron—Diarrhoea—Olmesartan—coronary artery disease	0.000105	0.000673	CcSEcCtD
Mirabegron—Headache—Eplerenone—coronary artery disease	0.000105	0.000673	CcSEcCtD
Mirabegron—Pruritus—Pravastatin—coronary artery disease	0.000104	0.000669	CcSEcCtD
Mirabegron—Nausea—Clopidogrel—coronary artery disease	0.000104	0.000669	CcSEcCtD
Mirabegron—Tachycardia—Ramipril—coronary artery disease	0.000104	0.000669	CcSEcCtD
Mirabegron—Skin disorder—Ramipril—coronary artery disease	0.000104	0.000665	CcSEcCtD
Mirabegron—Infection—Timolol—coronary artery disease	0.000104	0.000665	CcSEcCtD
Mirabegron—Nausea—Lovastatin—coronary artery disease	0.000104	0.000664	CcSEcCtD
Mirabegron—Rash—Simvastatin—coronary artery disease	0.000103	0.00066	CcSEcCtD
Mirabegron—Dermatitis—Simvastatin—coronary artery disease	0.000103	0.000659	CcSEcCtD
Mirabegron—Asthenia—Trandolapril—coronary artery disease	0.000103	0.000659	CcSEcCtD
Mirabegron—Urticaria—Furosemide—coronary artery disease	0.000103	0.000658	CcSEcCtD
Mirabegron—Diarrhoea—Niacin—coronary artery disease	0.000102	0.000657	CcSEcCtD
Mirabegron—Asthenia—Enalapril—coronary artery disease	0.000102	0.000656	CcSEcCtD
Mirabegron—Headache—Simvastatin—coronary artery disease	0.000102	0.000655	CcSEcCtD
Mirabegron—Abdominal pain—Furosemide—coronary artery disease	0.000102	0.000655	CcSEcCtD
Mirabegron—Gastrointestinal pain—Losartan—coronary artery disease	0.000102	0.000653	CcSEcCtD
Mirabegron—Dizziness—Valsartan—coronary artery disease	0.000102	0.000653	CcSEcCtD
Mirabegron—Nausea—Ezetimibe—coronary artery disease	0.000102	0.000652	CcSEcCtD
Mirabegron—Skin disorder—Timolol—coronary artery disease	0.000101	0.000651	CcSEcCtD
Mirabegron—Dizziness—Olmesartan—coronary artery disease	0.000101	0.00065	CcSEcCtD
Mirabegron—Pruritus—Trandolapril—coronary artery disease	0.000101	0.00065	CcSEcCtD
Mirabegron—Arthralgia—Lisinopril—coronary artery disease	0.000101	0.000648	CcSEcCtD
Mirabegron—Asthenia—Telmisartan—coronary artery disease	0.000101	0.000647	CcSEcCtD
Mirabegron—Pruritus—Enalapril—coronary artery disease	0.000101	0.000647	CcSEcCtD
Mirabegron—Diarrhoea—Pravastatin—coronary artery disease	0.000101	0.000647	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.0001	0.000644	CcSEcCtD
Mirabegron—Pruritus—Telmisartan—coronary artery disease	9.95e-05	0.000638	CcSEcCtD
Mirabegron—Nausea—Eplerenone—coronary artery disease	9.94e-05	0.000638	CcSEcCtD
Mirabegron—Dizziness—Niacin—coronary artery disease	9.9e-05	0.000635	CcSEcCtD
Mirabegron—Urticaria—Losartan—coronary artery disease	9.89e-05	0.000635	CcSEcCtD
Mirabegron—Dry mouth—Lisinopril—coronary artery disease	9.88e-05	0.000634	CcSEcCtD
Mirabegron—Abdominal pain—Losartan—coronary artery disease	9.84e-05	0.000632	CcSEcCtD
Mirabegron—Asthenia—Captopril—coronary artery disease	9.81e-05	0.000629	CcSEcCtD
Mirabegron—Diarrhoea—Trandolapril—coronary artery disease	9.79e-05	0.000628	CcSEcCtD
Mirabegron—Diarrhoea—Enalapril—coronary artery disease	9.75e-05	0.000626	CcSEcCtD
Mirabegron—Dizziness—Pravastatin—coronary artery disease	9.75e-05	0.000625	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Ramipril—coronary artery disease	9.73e-05	0.000624	CcSEcCtD
Mirabegron—Rash—Valsartan—coronary artery disease	9.71e-05	0.000623	CcSEcCtD
Mirabegron—Dermatitis—Valsartan—coronary artery disease	9.7e-05	0.000622	CcSEcCtD
Mirabegron—Nausea—Simvastatin—coronary artery disease	9.68e-05	0.000621	CcSEcCtD
Mirabegron—Pruritus—Captopril—coronary artery disease	9.67e-05	0.000621	CcSEcCtD
Mirabegron—Rash—Olmesartan—coronary artery disease	9.66e-05	0.00062	CcSEcCtD
Mirabegron—Dermatitis—Olmesartan—coronary artery disease	9.65e-05	0.000619	CcSEcCtD
Mirabegron—Headache—Valsartan—coronary artery disease	9.65e-05	0.000619	CcSEcCtD
Mirabegron—Diarrhoea—Telmisartan—coronary artery disease	9.62e-05	0.000617	CcSEcCtD
Mirabegron—Infection—Lisinopril—coronary artery disease	9.62e-05	0.000617	CcSEcCtD
Mirabegron—Headache—Olmesartan—coronary artery disease	9.6e-05	0.000616	CcSEcCtD
Mirabegron—Asthenia—Perindopril—coronary artery disease	9.52e-05	0.000611	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Timolol—coronary artery disease	9.51e-05	0.00061	CcSEcCtD
Mirabegron—Dizziness—Trandolapril—coronary artery disease	9.47e-05	0.000607	CcSEcCtD
Mirabegron—Tachycardia—Lisinopril—coronary artery disease	9.45e-05	0.000606	CcSEcCtD
Mirabegron—Rash—Niacin—coronary artery disease	9.44e-05	0.000606	CcSEcCtD
Mirabegron—Dermatitis—Niacin—coronary artery disease	9.43e-05	0.000605	CcSEcCtD
Mirabegron—Dizziness—Enalapril—coronary artery disease	9.43e-05	0.000605	CcSEcCtD
Mirabegron—Skin disorder—Lisinopril—coronary artery disease	9.41e-05	0.000603	CcSEcCtD
Mirabegron—Dyspepsia—Ramipril—coronary artery disease	9.4e-05	0.000603	CcSEcCtD
Mirabegron—Pruritus—Perindopril—coronary artery disease	9.39e-05	0.000603	CcSEcCtD
Mirabegron—Headache—Niacin—coronary artery disease	9.38e-05	0.000602	CcSEcCtD
Mirabegron—Diarrhoea—Captopril—coronary artery disease	9.36e-05	0.0006	CcSEcCtD
Mirabegron—Dizziness—Telmisartan—coronary artery disease	9.3e-05	0.000597	CcSEcCtD
Mirabegron—Rash—Pravastatin—coronary artery disease	9.29e-05	0.000596	CcSEcCtD
Mirabegron—Dermatitis—Pravastatin—coronary artery disease	9.29e-05	0.000596	CcSEcCtD
Mirabegron—Asthenia—Furosemide—coronary artery disease	9.26e-05	0.000594	CcSEcCtD
Mirabegron—Headache—Pravastatin—coronary artery disease	9.23e-05	0.000592	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Ramipril—coronary artery disease	9.22e-05	0.000591	CcSEcCtD
Mirabegron—Fatigue—Ramipril—coronary artery disease	9.21e-05	0.000591	CcSEcCtD
Mirabegron—Dyspepsia—Timolol—coronary artery disease	9.19e-05	0.00059	CcSEcCtD
Mirabegron—Nausea—Valsartan—coronary artery disease	9.15e-05	0.000587	CcSEcCtD
Mirabegron—Pruritus—Furosemide—coronary artery disease	9.13e-05	0.000586	CcSEcCtD
Mirabegron—Constipation—Ramipril—coronary artery disease	9.13e-05	0.000586	CcSEcCtD
Mirabegron—Nausea—Olmesartan—coronary artery disease	9.1e-05	0.000584	CcSEcCtD
Mirabegron—Diarrhoea—Perindopril—coronary artery disease	9.08e-05	0.000583	CcSEcCtD
Mirabegron—Dizziness—Captopril—coronary artery disease	9.04e-05	0.00058	CcSEcCtD
Mirabegron—Rash—Trandolapril—coronary artery disease	9.02e-05	0.000579	CcSEcCtD
Mirabegron—Dermatitis—Trandolapril—coronary artery disease	9.02e-05	0.000579	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Timolol—coronary artery disease	9.01e-05	0.000578	CcSEcCtD
Mirabegron—Fatigue—Timolol—coronary artery disease	9e-05	0.000577	CcSEcCtD
Mirabegron—Rash—Enalapril—coronary artery disease	8.99e-05	0.000577	CcSEcCtD
Mirabegron—Dermatitis—Enalapril—coronary artery disease	8.98e-05	0.000576	CcSEcCtD
Mirabegron—Headache—Trandolapril—coronary artery disease	8.97e-05	0.000575	CcSEcCtD
Mirabegron—Asthenia—Losartan—coronary artery disease	8.93e-05	0.000573	CcSEcCtD
Mirabegron—Headache—Enalapril—coronary artery disease	8.93e-05	0.000573	CcSEcCtD
Mirabegron—Nausea—Niacin—coronary artery disease	8.89e-05	0.000571	CcSEcCtD
Mirabegron—Rash—Telmisartan—coronary artery disease	8.87e-05	0.000569	CcSEcCtD
Mirabegron—Dermatitis—Telmisartan—coronary artery disease	8.86e-05	0.000568	CcSEcCtD
Mirabegron—Diarrhoea—Furosemide—coronary artery disease	8.83e-05	0.000567	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Lisinopril—coronary artery disease	8.82e-05	0.000566	CcSEcCtD
Mirabegron—Pruritus—Losartan—coronary artery disease	8.81e-05	0.000565	CcSEcCtD
Mirabegron—Headache—Telmisartan—coronary artery disease	8.81e-05	0.000565	CcSEcCtD
Mirabegron—Dizziness—Perindopril—coronary artery disease	8.78e-05	0.000563	CcSEcCtD
Mirabegron—Nausea—Pravastatin—coronary artery disease	8.76e-05	0.000562	CcSEcCtD
Mirabegron—Gastrointestinal pain—Ramipril—coronary artery disease	8.73e-05	0.00056	CcSEcCtD
Mirabegron—Rash—Captopril—coronary artery disease	8.62e-05	0.000553	CcSEcCtD
Mirabegron—Dermatitis—Captopril—coronary artery disease	8.61e-05	0.000553	CcSEcCtD
Mirabegron—Headache—Captopril—coronary artery disease	8.57e-05	0.00055	CcSEcCtD
Mirabegron—Gastrointestinal pain—Timolol—coronary artery disease	8.54e-05	0.000548	CcSEcCtD
Mirabegron—Dizziness—Furosemide—coronary artery disease	8.53e-05	0.000548	CcSEcCtD
Mirabegron—Dyspepsia—Lisinopril—coronary artery disease	8.52e-05	0.000547	CcSEcCtD
Mirabegron—Diarrhoea—Losartan—coronary artery disease	8.52e-05	0.000547	CcSEcCtD
Mirabegron—Nausea—Trandolapril—coronary artery disease	8.5e-05	0.000546	CcSEcCtD
Mirabegron—Urticaria—Ramipril—coronary artery disease	8.48e-05	0.000544	CcSEcCtD
Mirabegron—Nausea—Enalapril—coronary artery disease	8.47e-05	0.000543	CcSEcCtD
Mirabegron—Abdominal pain—Ramipril—coronary artery disease	8.44e-05	0.000542	CcSEcCtD
Mirabegron—Rash—Perindopril—coronary artery disease	8.37e-05	0.000537	CcSEcCtD
Mirabegron—Dermatitis—Perindopril—coronary artery disease	8.36e-05	0.000537	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Lisinopril—coronary artery disease	8.36e-05	0.000536	CcSEcCtD
Mirabegron—Nausea—Telmisartan—coronary artery disease	8.35e-05	0.000536	CcSEcCtD
Mirabegron—Fatigue—Lisinopril—coronary artery disease	8.35e-05	0.000536	CcSEcCtD
Mirabegron—Headache—Perindopril—coronary artery disease	8.32e-05	0.000534	CcSEcCtD
Mirabegron—Urticaria—Timolol—coronary artery disease	8.29e-05	0.000532	CcSEcCtD
Mirabegron—Constipation—Lisinopril—coronary artery disease	8.28e-05	0.000531	CcSEcCtD
Mirabegron—Abdominal pain—Timolol—coronary artery disease	8.25e-05	0.000529	CcSEcCtD
Mirabegron—Dizziness—Losartan—coronary artery disease	8.23e-05	0.000528	CcSEcCtD
Mirabegron—Rash—Furosemide—coronary artery disease	8.14e-05	0.000522	CcSEcCtD
Mirabegron—Dermatitis—Furosemide—coronary artery disease	8.13e-05	0.000522	CcSEcCtD
Mirabegron—Nausea—Captopril—coronary artery disease	8.12e-05	0.000521	CcSEcCtD
Mirabegron—Headache—Furosemide—coronary artery disease	8.08e-05	0.000519	CcSEcCtD
Mirabegron—Gastrointestinal pain—Lisinopril—coronary artery disease	7.92e-05	0.000508	CcSEcCtD
Mirabegron—Nausea—Perindopril—coronary artery disease	7.89e-05	0.000506	CcSEcCtD
Mirabegron—Rash—Losartan—coronary artery disease	7.85e-05	0.000504	CcSEcCtD
Mirabegron—Dermatitis—Losartan—coronary artery disease	7.84e-05	0.000503	CcSEcCtD
Mirabegron—Headache—Losartan—coronary artery disease	7.8e-05	0.000501	CcSEcCtD
Mirabegron—Urticaria—Lisinopril—coronary artery disease	7.69e-05	0.000494	CcSEcCtD
Mirabegron—Nausea—Furosemide—coronary artery disease	7.67e-05	0.000492	CcSEcCtD
Mirabegron—Asthenia—Ramipril—coronary artery disease	7.66e-05	0.000492	CcSEcCtD
Mirabegron—Abdominal pain—Lisinopril—coronary artery disease	7.65e-05	0.000491	CcSEcCtD
Mirabegron—Pruritus—Ramipril—coronary artery disease	7.55e-05	0.000485	CcSEcCtD
Mirabegron—Asthenia—Timolol—coronary artery disease	7.49e-05	0.000481	CcSEcCtD
Mirabegron—Nausea—Losartan—coronary artery disease	7.4e-05	0.000475	CcSEcCtD
Mirabegron—Pruritus—Timolol—coronary artery disease	7.38e-05	0.000474	CcSEcCtD
Mirabegron—Diarrhoea—Ramipril—coronary artery disease	7.31e-05	0.000469	CcSEcCtD
Mirabegron—Diarrhoea—Timolol—coronary artery disease	7.14e-05	0.000458	CcSEcCtD
Mirabegron—Dizziness—Ramipril—coronary artery disease	7.06e-05	0.000453	CcSEcCtD
Mirabegron—Asthenia—Lisinopril—coronary artery disease	6.95e-05	0.000446	CcSEcCtD
Mirabegron—Dizziness—Timolol—coronary artery disease	6.9e-05	0.000443	CcSEcCtD
Mirabegron—Pruritus—Lisinopril—coronary artery disease	6.85e-05	0.00044	CcSEcCtD
Mirabegron—Rash—Ramipril—coronary artery disease	6.73e-05	0.000432	CcSEcCtD
Mirabegron—Dermatitis—Ramipril—coronary artery disease	6.73e-05	0.000432	CcSEcCtD
Mirabegron—Headache—Ramipril—coronary artery disease	6.69e-05	0.000429	CcSEcCtD
Mirabegron—Diarrhoea—Lisinopril—coronary artery disease	6.63e-05	0.000425	CcSEcCtD
Mirabegron—Rash—Timolol—coronary artery disease	6.58e-05	0.000422	CcSEcCtD
Mirabegron—Dermatitis—Timolol—coronary artery disease	6.58e-05	0.000422	CcSEcCtD
Mirabegron—Headache—Timolol—coronary artery disease	6.54e-05	0.00042	CcSEcCtD
Mirabegron—Dizziness—Lisinopril—coronary artery disease	6.4e-05	0.000411	CcSEcCtD
Mirabegron—Nausea—Ramipril—coronary artery disease	6.34e-05	0.000407	CcSEcCtD
Mirabegron—Nausea—Timolol—coronary artery disease	6.2e-05	0.000398	CcSEcCtD
Mirabegron—Rash—Lisinopril—coronary artery disease	6.11e-05	0.000392	CcSEcCtD
Mirabegron—Dermatitis—Lisinopril—coronary artery disease	6.1e-05	0.000391	CcSEcCtD
Mirabegron—Headache—Lisinopril—coronary artery disease	6.07e-05	0.000389	CcSEcCtD
Mirabegron—Nausea—Lisinopril—coronary artery disease	5.75e-05	0.000369	CcSEcCtD
Mirabegron—BCHE—Metabolism—MTHFR—coronary artery disease	6.29e-06	8.52e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—P4HB—coronary artery disease	6.23e-06	8.44e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTT1—coronary artery disease	6.22e-06	8.43e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC9A1—coronary artery disease	6.22e-06	8.43e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CETP—coronary artery disease	6.15e-06	8.34e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GCLC—coronary artery disease	6.15e-06	8.34e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—VCAN—coronary artery disease	6.12e-06	8.29e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	6.12e-06	8.29e-05	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PIK3CA—coronary artery disease	6.09e-06	8.25e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SDC1—coronary artery disease	6.08e-06	8.24e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SERPINE1—coronary artery disease	6.08e-06	8.23e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALDOA—coronary artery disease	6.07e-06	8.23e-05	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	6.03e-06	8.17e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS3—coronary artery disease	6.03e-06	8.17e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.99e-06	8.12e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AGT—coronary artery disease	5.98e-06	8.1e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—DCN—coronary artery disease	5.89e-06	7.98e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGF2—coronary artery disease	5.88e-06	7.97e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—JAK2—coronary artery disease	5.86e-06	7.94e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOE—coronary artery disease	5.86e-06	7.94e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—coronary artery disease	5.81e-06	7.88e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOS3—coronary artery disease	5.8e-06	7.86e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOA1—coronary artery disease	5.79e-06	7.84e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—VCAN—coronary artery disease	5.77e-06	7.81e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PSMA6—coronary artery disease	5.75e-06	7.79e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PSMB5—coronary artery disease	5.75e-06	7.79e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—POMC—coronary artery disease	5.73e-06	7.77e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALDH2—coronary artery disease	5.73e-06	7.77e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDOA—coronary artery disease	5.72e-06	7.75e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.72e-06	7.75e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HK2—coronary artery disease	5.72e-06	7.75e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—JAK2—coronary artery disease	5.64e-06	7.64e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CTGF—coronary artery disease	5.61e-06	7.61e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3C2A—coronary artery disease	5.59e-06	7.57e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2C19—coronary artery disease	5.59e-06	7.57e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LIPC—coronary artery disease	5.59e-06	7.57e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HBA1—coronary artery disease	5.59e-06	7.57e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMGCR—coronary artery disease	5.56e-06	7.54e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GOT2—coronary artery disease	5.56e-06	7.54e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—DCN—coronary artery disease	5.55e-06	7.52e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOC3—coronary artery disease	5.55e-06	7.52e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.54e-06	7.51e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CA—coronary artery disease	5.53e-06	7.49e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LDLR—coronary artery disease	5.52e-06	7.48e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.48e-06	7.43e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTT1—coronary artery disease	5.45e-06	7.39e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC9A1—coronary artery disease	5.45e-06	7.39e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDH2—coronary artery disease	5.4e-06	7.32e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CETP—coronary artery disease	5.39e-06	7.3e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GCLC—coronary artery disease	5.39e-06	7.3e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CPT1B—coronary artery disease	5.38e-06	7.28e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LCAT—coronary artery disease	5.38e-06	7.28e-05	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	5.37e-06	7.28e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SDC1—coronary artery disease	5.33e-06	7.22e-05	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	5.29e-06	7.17e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA4—coronary artery disease	5.28e-06	7.15e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HBA1—coronary artery disease	5.26e-06	7.13e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2C19—coronary artery disease	5.26e-06	7.13e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	5.26e-06	7.13e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LIPC—coronary artery disease	5.26e-06	7.13e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOC3—coronary artery disease	5.23e-06	7.09e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALB—coronary artery disease	5.23e-06	7.08e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LDLR—coronary artery disease	5.2e-06	7.05e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCL8—coronary artery disease	5.15e-06	6.97e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC9A1—coronary artery disease	5.14e-06	6.96e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTT1—coronary artery disease	5.14e-06	6.96e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PLCB1—coronary artery disease	5.12e-06	6.93e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—coronary artery disease	5.1e-06	6.91e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PDHA1—coronary artery disease	5.1e-06	6.9e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GCLM—coronary artery disease	5.1e-06	6.9e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GCLC—coronary artery disease	5.08e-06	6.88e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CETP—coronary artery disease	5.08e-06	6.88e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PSMA6—coronary artery disease	5.04e-06	6.82e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PSMB5—coronary artery disease	5.04e-06	6.82e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—POMC—coronary artery disease	5.03e-06	6.82e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SDC1—coronary artery disease	5.02e-06	6.8e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.02e-06	6.8e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NOS3—coronary artery disease	5e-06	6.78e-05	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT1—coronary artery disease	4.97e-06	6.74e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCA1—coronary artery disease	4.96e-06	6.72e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.94e-06	6.69e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.94e-06	6.69e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CASP3—coronary artery disease	4.93e-06	6.67e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CTGF—coronary artery disease	4.92e-06	6.66e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—coronary artery disease	4.89e-06	6.63e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMGCR—coronary artery disease	4.87e-06	6.6e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GOT2—coronary artery disease	4.87e-06	6.6e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.86e-06	6.59e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GGT1—coronary artery disease	4.8e-06	6.51e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GOT1—coronary artery disease	4.8e-06	6.51e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCND1—coronary artery disease	4.79e-06	6.5e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.79e-06	6.49e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HADH—coronary artery disease	4.79e-06	6.49e-05	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	4.78e-06	6.47e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PSMB5—coronary artery disease	4.74e-06	6.43e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PSMA6—coronary artery disease	4.74e-06	6.43e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—coronary artery disease	4.66e-06	6.31e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CTGF—coronary artery disease	4.64e-06	6.28e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMGCR—coronary artery disease	4.59e-06	6.22e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GOT2—coronary artery disease	4.59e-06	6.22e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALB—coronary artery disease	4.59e-06	6.22e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—coronary artery disease	4.57e-06	6.2e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.54e-06	6.15e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA2—coronary artery disease	4.54e-06	6.15e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPX2—coronary artery disease	4.54e-06	6.15e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT1—coronary artery disease	4.51e-06	6.12e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HK1—coronary artery disease	4.49e-06	6.08e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.49e-06	6.08e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPX4—coronary artery disease	4.49e-06	6.08e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.49e-06	6.08e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLCB1—coronary artery disease	4.48e-06	6.07e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HADHA—coronary artery disease	4.43e-06	6.01e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NOS3—coronary artery disease	4.39e-06	5.95e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.38e-06	5.94e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ABCA1—coronary artery disease	4.34e-06	5.89e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—coronary artery disease	4.34e-06	5.88e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LPA—coronary artery disease	4.33e-06	5.87e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTP1—coronary artery disease	4.31e-06	5.84e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARGC1A—coronary artery disease	4.27e-06	5.79e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMOX1—coronary artery disease	4.25e-06	5.76e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLCB1—coronary artery disease	4.22e-06	5.72e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GGT1—coronary artery disease	4.21e-06	5.7e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GOT1—coronary artery disease	4.21e-06	5.7e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CAT—coronary artery disease	4.2e-06	5.69e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.2e-06	5.69e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—coronary artery disease	4.18e-06	5.66e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA5—coronary artery disease	4.15e-06	5.63e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCA1—coronary artery disease	4.09e-06	5.55e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOB—coronary artery disease	4.08e-06	5.52e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—P4HB—coronary artery disease	4.07e-06	5.52e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—coronary artery disease	4.01e-06	5.44e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4e-06	5.42e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TGFB1—coronary artery disease	3.99e-06	5.4e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GOT1—coronary artery disease	3.97e-06	5.37e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GGT1—coronary artery disease	3.97e-06	5.37e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTM1—coronary artery disease	3.96e-06	5.37e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MAPK1—coronary artery disease	3.91e-06	5.3e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—LPL—coronary artery disease	3.89e-06	5.27e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TGFB1—coronary artery disease	3.84e-06	5.2e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GPX1—coronary artery disease	3.8e-06	5.14e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTP1—coronary artery disease	3.78e-06	5.12e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—VCAN—coronary artery disease	3.77e-06	5.11e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK1—coronary artery disease	3.76e-06	5.1e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARGC1A—coronary artery disease	3.74e-06	5.07e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.74e-06	5.07e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMOX1—coronary artery disease	3.73e-06	5.05e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CD36—coronary artery disease	3.7e-06	5.01e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CAT—coronary artery disease	3.68e-06	4.98e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPP2CA—coronary artery disease	3.65e-06	4.95e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—DCN—coronary artery disease	3.63e-06	4.92e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOB—coronary artery disease	3.57e-06	4.84e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.56e-06	4.83e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.53e-06	4.79e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.53e-06	4.78e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.51e-06	4.76e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—coronary artery disease	3.5e-06	4.75e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTM1—coronary artery disease	3.47e-06	4.71e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CAT—coronary artery disease	3.47e-06	4.7e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LIPC—coronary artery disease	3.44e-06	4.66e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HBA1—coronary artery disease	3.44e-06	4.66e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.44e-06	4.66e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.44e-06	4.66e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOC3—coronary artery disease	3.42e-06	4.63e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LPL—coronary artery disease	3.41e-06	4.62e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LDLR—coronary artery disease	3.4e-06	4.61e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CA—coronary artery disease	3.39e-06	4.59e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOB—coronary artery disease	3.36e-06	4.56e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.36e-06	4.55e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.36e-06	4.55e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AGT—coronary artery disease	3.33e-06	4.51e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GPX1—coronary artery disease	3.33e-06	4.51e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GCLC—coronary artery disease	3.32e-06	4.5e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CETP—coronary artery disease	3.32e-06	4.5e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SDC1—coronary artery disease	3.28e-06	4.45e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.27e-06	4.43e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CA—coronary artery disease	3.26e-06	4.42e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOE—coronary artery disease	3.26e-06	4.42e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CD36—coronary artery disease	3.24e-06	4.39e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOA1—coronary artery disease	3.22e-06	4.37e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LPL—coronary artery disease	3.21e-06	4.35e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPP2CA—coronary artery disease	3.2e-06	4.33e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GPX1—coronary artery disease	3.13e-06	4.25e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.1e-06	4.2e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.1e-06	4.2e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.09e-06	4.18e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—coronary artery disease	3.07e-06	4.16e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CD36—coronary artery disease	3.05e-06	4.14e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CTGF—coronary artery disease	3.03e-06	4.11e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.01e-06	4.08e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMGCR—coronary artery disease	3e-06	4.07e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GOT2—coronary artery disease	3e-06	4.07e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AGT—coronary artery disease	2.92e-06	3.95e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.89e-06	3.92e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—coronary artery disease	2.89e-06	3.92e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOE—coronary artery disease	2.86e-06	3.87e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—coronary artery disease	2.84e-06	3.85e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOA1—coronary artery disease	2.83e-06	3.83e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CA—coronary artery disease	2.81e-06	3.81e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—POMC—coronary artery disease	2.8e-06	3.8e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT1—coronary artery disease	2.77e-06	3.75e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.76e-06	3.74e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AGT—coronary artery disease	2.75e-06	3.72e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOE—coronary artery disease	2.69e-06	3.65e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.68e-06	3.63e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT1—coronary artery disease	2.67e-06	3.61e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOA1—coronary artery disease	2.66e-06	3.61e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GOT1—coronary artery disease	2.59e-06	3.51e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GGT1—coronary artery disease	2.59e-06	3.51e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—coronary artery disease	2.49e-06	3.37e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CA—coronary artery disease	2.47e-06	3.35e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—POMC—coronary artery disease	2.46e-06	3.33e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NOS3—coronary artery disease	2.44e-06	3.31e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—coronary artery disease	2.35e-06	3.18e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.33e-06	3.16e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—POMC—coronary artery disease	2.31e-06	3.13e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.31e-06	3.13e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKT1—coronary artery disease	2.3e-06	3.11e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.3e-06	3.11e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CAT—coronary artery disease	2.27e-06	3.07e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALB—coronary artery disease	2.24e-06	3.03e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—coronary artery disease	2.23e-06	3.03e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOB—coronary artery disease	2.2e-06	2.98e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NOS3—coronary artery disease	2.14e-06	2.9e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.14e-06	2.9e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALB—coronary artery disease	2.11e-06	2.86e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LPL—coronary artery disease	2.1e-06	2.85e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPX1—coronary artery disease	2.05e-06	2.78e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NOS3—coronary artery disease	2.02e-06	2.73e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKT1—coronary artery disease	2.02e-06	2.73e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CD36—coronary artery disease	2e-06	2.7e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.97e-06	2.67e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—coronary artery disease	1.96e-06	2.65e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.89e-06	2.56e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.85e-06	2.5e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AGT—coronary artery disease	1.8e-06	2.43e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOE—coronary artery disease	1.76e-06	2.39e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA1—coronary artery disease	1.74e-06	2.36e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—coronary artery disease	1.53e-06	2.08e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—POMC—coronary artery disease	1.51e-06	2.05e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALB—coronary artery disease	1.38e-06	1.87e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CA—coronary artery disease	1.38e-06	1.86e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NOS3—coronary artery disease	1.32e-06	1.79e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.21e-06	1.63e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.2e-06	1.63e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.14e-06	1.54e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKT1—coronary artery disease	1.12e-06	1.52e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKT1—coronary artery disease	9.84e-07	1.33e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKT1—coronary artery disease	9.27e-07	1.26e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.42e-07	1.01e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKT1—coronary artery disease	6.06e-07	8.22e-06	CbGpPWpGaD
